These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 4013160)

  • 1. [Morphofunctional changes in the myocardium after administration of adrenaline and phosphodiesterase inhibitors].
    Sergienko OV
    Vrach Delo; 1985 Mar; (3):36-9. PubMed ID: 4013160
    [No Abstract]   [Full Text] [Related]  

  • 2. [Structural changes in the myocardium caused by repeated administration of adrenaline and pituitrin].
    Gichka SG
    Vrach Delo; 1984 Apr; (4):34-7. PubMed ID: 6204457
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac anti-remodelling effects of phosphodiesterase type 5 inhibitors: afterload-(in)dependent?
    Kuhn M
    Cardiovasc Res; 2009 Apr; 82(1):4-6. PubMed ID: 19221131
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of cyclic AMP phosphodiesterase inhibitors on cardiac sarcolemmal 5'-nucleotidase.
    Heyliger CE; Panagia V; Dhalla NS
    J Pharmacol Exp Ther; 1981 May; 217(2):489-93. PubMed ID: 6262487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The course of experimental pulmonary edema as a function of the dose and time of administration of adrenaline, pilocarpine and caffeine].
    Gervazieva ID
    Vrach Delo; 1966 May; 5():43-5. PubMed ID: 5995507
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inadvertent intravenous injection of adrenaline].
    Lübbecke F
    Dtsch Med Wochenschr; 1999 Jan; 124(3):66-7. PubMed ID: 9987491
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
    Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
    Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of two phosphodiesterase inhibitors, theophylline and papaverine, on blood glucose, plasma FFA and glycerol in the rat.
    Mäkeläinen A; Vapaatalo H; Nikki P
    Arzneimittelforschung; 1973 Jun; 23(6):882-3. PubMed ID: 4353588
    [No Abstract]   [Full Text] [Related]  

  • 9. The positive inotropic effect of cyclic AMP.
    Kukovetz WR; Pöch G
    Adv Cyclic Nucleotide Res; 1972; 1():261-90. PubMed ID: 4353171
    [No Abstract]   [Full Text] [Related]  

  • 10. Caffeine as a novel addition to the antivitiligo ammunition.
    Feily A; Saboktakin M
    G Ital Dermatol Venereol; 2010 Feb; 145(1):139. PubMed ID: 20197754
    [No Abstract]   [Full Text] [Related]  

  • 11. [Age-related sensitivity of the myocardium and its metabolism in single and multiple administrations of adrenaline].
    Danilova KM; Klibaner MI
    Arkh Patol; 1974; 36(8):34-40. PubMed ID: 4451508
    [No Abstract]   [Full Text] [Related]  

  • 12. [Morphological patterns of the development of experimental adrenaline injuries to the myocardium].
    Sergienko OV
    Vrach Delo; 1984 Jul; (7):61-4. PubMed ID: 6475023
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of four methylxanthine compounds and norepinephrine on cardiac phosphorylase activation and cardiac contractility.
    McNeill JH; Brenner MJ; Muschek LD
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():261-73. PubMed ID: 4377599
    [No Abstract]   [Full Text] [Related]  

  • 14. Study of phosphodiesterase inhibitors on lipolysis, phosphodiesterase activity and cyclic 3',5'-adenosine monophosphate levels in isolated fat cells.
    Allen DO; Clark JF; Ashmore J
    J Pharmacol Exp Ther; 1973 May; 185(2):379-85. PubMed ID: 4350040
    [No Abstract]   [Full Text] [Related]  

  • 15. Buffered papaverine facilitates passage of intratympanic dexamethasone to the inner ear.
    Naci Ozluoglu L; Yilmaz I; Akkuzu B; Haberal A
    Acta Otolaryngol; 2006 Dec; 126(12):1260-5. PubMed ID: 17101586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dynamics of changes in the phosphorolytic and hydrolytic activity in the myocardium and skeletal muscle during adrenaline infusion.
    Wilczek J
    Acta Physiol Pol; 1982; 33(4):265-72. PubMed ID: 7184311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic and pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 63291 and WIN 62582.
    Pagani ED; Dundore RL; Bode DC; Bacon ER; Singh B; Lesher GY; Buchholz RA; Silver PJ
    J Cardiovasc Pharmacol; 1994 Sep; 24(3):403-10. PubMed ID: 7528296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships for inhibitors of phosphodiesterase from erythrocytes and other tissues.
    Sheppard H; Wiggan G; Tsien WH
    Adv Cyclic Nucleotide Res; 1972; 1():103-12. PubMed ID: 4354559
    [No Abstract]   [Full Text] [Related]  

  • 19. Phosphodiesterase inhibition as a mechanism for the diuretic activity of 1 ((tert-butylimino)methyl)-2-(3-indolyl)indoline hydrochloride (MJ-8592-1).
    Amer MS; Gomoll AW; McKinney GR
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):467-76. PubMed ID: 4342315
    [No Abstract]   [Full Text] [Related]  

  • 20. [Changes in the stroma of the heart in adrenaline-induced lesions of the myocardium].
    Tsellarius IuG; Semenova LA
    Arkh Patol; 1971; 33(11):43-9. PubMed ID: 4260138
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.